Compare TRMD & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRMD | ITGR |
|---|---|---|
| Founded | 1889 | 1970 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.7B |
| IPO Year | N/A | 2000 |
| Metric | TRMD | ITGR |
|---|---|---|
| Price | $22.46 | $84.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $23.00 | ★ $95.00 |
| AVG Volume (30 Days) | 516.6K | ★ 626.8K |
| Earning Date | 11-06-2025 | 02-19-2026 |
| Dividend Yield | ★ 8.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.76 | 2.42 |
| Revenue | $1,292,300,000.00 | ★ $1,831,074,000.00 |
| Revenue This Year | N/A | $9.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $8.27 | $34.65 |
| Revenue Growth | N/A | ★ 9.54 |
| 52 Week Low | $13.60 | $62.00 |
| 52 Week High | $23.67 | $146.36 |
| Indicator | TRMD | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 67.86 | 73.86 |
| Support Level | $19.46 | $80.17 |
| Resistance Level | $23.11 | $79.48 |
| Average True Range (ATR) | 0.44 | 2.18 |
| MACD | 0.41 | 0.67 |
| Stochastic Oscillator | 83.20 | 94.06 |
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.